Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis

Frontiers in Bioscience

Volumn 12, Issue 12, 2007, Pages 4439-4455

  Gonzalez Navarro, Herminia ^a   Burks, Deborah J ^b   Andres, Vicente ^a  

^a INSTITUTO DE BIOMECÁNICA DE VALENCIA   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

Atherosclerosis; Chronic inflammation; Diabetes mellitus; Genetically modified mice; Hypercholesterolemia; Insulin resistance; IRS; Metabolic syndrome; Restenosis; Review

Indexed keywords

MURINAE; MUS;

GLUCOSE; INSULIN; LEPTIN;

ANIMAL; ATHEROSCLEROSIS; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; INTIMA; METABOLISM; MOUSE; PATHOLOGY; RECURRENT DISEASE; REVIEW; STENOSIS, OCCLUSION AND OBSTRUCTION;

ANIMALS; ATHEROSCLEROSIS; CONSTRICTION, PATHOLOGIC; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; GLUCOSE; INSULIN; LEPTIN; MICE; RECURRENCE; TUNICA INTIMA;

EID: 34347251212     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2400     Document Type: Review

References (146)

1. Lusis A. J.: Atherosclerosis. Nature 407, 233-241. (2000)
2. Ross R.: Atherosclerosis: an inflammatory disease. N Engl J Med 340, 115-126 (1999)
3. Glass C. K. & J. L. Witztum: Atherosclerosis. the road ahead. Cell 104, 503-516 (2001)
4. Steinberg D.: Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8, 1211-1217 (2002) (Pubitemid 35373551)
5. Binder C. J., M. K. Chang, P. X. Shaw, Y. I. Miller, K. Hartvigsen, A. Dewan & J. L. Witztum: Innate and acquired immunity in atherogenesis. Nat Med 8, 1218-1226 (2002) (Pubitemid 35373552)
6. Greaves D. R. & K. M. Channon: Inflammation and immune responses in atherosclerosis. Trends Immunol 23, 535-541 (2002) (Pubitemid 35223552)
7. Gerstein H. C. & S. Yusuf: Dysglycaemia and risk of cardiovascular disease. Lancet 347, 949-950 (1996) (Pubitemid 26102554)
8. Beckman J. A., M. A. Creager & P. Libby: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Jama 287, 2570-2581 (2002) (Pubitemid 34517204)
9. Stolar M. W. & R. J. Chilton: Type 2 diabetes, cardiovascular risk, and the link to insulin resistance. Clin Ther 25 Suppl B, B4-31 (2003) (Pubitemid 37072283)
10. Askari B., C. B. Renard & K. E. Bornfeldt: Regulation of smooth muscle cell accumulation in diabetes-accelerated atherosclerosis. Histol Histopathol 17, 1317-1328 (2002)
11. Moreno P. R. & V. Fuster: New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 44, 2293-2300 (2004) (Pubitemid 39647601)
12. Reaven G.: Why Syndrome X? From Harold Himsworth to the Insulin Resistance Syndrome. Cell Metabolism 1, 9-14 (2005) (Pubitemid 43960585)
13. Di Carli M. F. & R. Hachamovitch: Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? J Am Coll Cardiol 45, 50-53 (2005) (Pubitemid 40052024)
14. Zimmet P., K. G. Alberti & J. Shaw: Global and societal implications of the diabetes epidemic. Nature 414, 782-787 (2001) (Pubitemid 34000780)
15. Notkins A. L. & A. Lernmark: Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 108, 1247-1252 (2001) (Pubitemid 33107747)
16. Trucco M.: Regeneration of the pancreatic beta cell. J Clin Invest 115, 5-12 (2005)
17. Creusot R. J. & C. G. Fathman: Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity. J Clin Invest 114, 892-894 (2004) (Pubitemid 39578715)
18. Tian C., J. Bagley, N. Cretin, N. Seth, K. W. Wucherpfennig & J. Iacomini: Prevention of type 1 diabetes by gene therapy. J Clin Invest 114, 969-978 (2004) (Pubitemid 39578725)
19. Rhodes C. J.: Type 2 diabetes-a matter of beta-cell life and death? Science 307, 380-384 (2005) (Pubitemid 40139973)
20. Ginsberg H. N.: Insulin resistance and cardiovascular disease. J Clin Invest 106, 453-458 (2000) (Pubitemid 30666377)
21. Brunzell J. D. & A. F. Ayyobi: Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med 115 Suppl 8 A, 24S-28S (2003)
22. Ayyobi A. F. & J. D. Brunzell: Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia. Am J Cardiol 92, 27J-33J (2003)
23. Kang H. S., B. Gutin, P. Barbeau, M. S. Litaker, J. Allison & N. A. Le: Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths. Int J Obes Relat Metab Disord 26, 1030-1035 (2002)
24. Sibley S. D., J. P. Palmer, I. B. Hirsch & J. D. Brunzell: Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. J Clin Endocrinol Metab 88, 3379-3384 (2003) (Pubitemid 36877520)
25. Goff D. C., B. D'Agostino R, S. M. Haffner & J. D. Otvos: Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 54, 264-270 (2005) (Pubitemid 40174857)
26. Evans M., N. Khan & A. Rees: Diabetic dyslipidaemia and coronary heart disease: new perspectives. Curr Opin Lipidol 10, 387-391 (1999) (Pubitemid 30025814)
27. Schwartz S. M. & K. E. Bornfeldt: How does diabetes accelerate atherosclerotic plaque rupture and arterial occlusion? Front Biosci 8, s1371-1383 (2003) (Pubitemid 38925394)
28. Steinberg H. O., H. Chaker, R. Leaming, A. Johnson, G. Brechtel & A. D. Baron: Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97, 2601-2610 (1996)
29. Taguchi S., T. Oinuma & T. Yamada: A comparative study of cultured smooth muscle cell proliferation and injury, utilizing glycated low density lipoproteins with slight oxidation, auto-oxidation, or extensive oxidation. J Atheroscler Thromb 7, 132-137 (2000)
30. Breslow J. L.: Mouse models of atherosclerosis. Science 272, 685-688 (1996) (Pubitemid 26000273)
31. Smithies O. & N. Maeda: Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc Natl Acad Sci U S A 92, 5266-5272 (1995)
32. Like A. A. & A. A. Rossini: Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415-417 (1976)
33. Bolzan A. D. & M. S. Bianchi: Genotoxicity of streptozotocin. Mutat Res 512, 121-134 (2002) (Pubitemid 35441051)
34. Inoguchi T., P. Xia, M. Kunisaki, S. Higashi, E. P. Feener & G. L. King: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 267, E369-379 (1994)
35. Xia P., T. Inoguchi, T. S. Kern, R. L. Engerman, P. J. Oates & G. L. King: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43, 1122-1129 (1994) (Pubitemid 24265474)
36. Kunjathoor V. V., D. L. Wilson & R. C. LeBoeuf: Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97, 1767-1773 (1996) (Pubitemid 26105486)
37. Zhang S. H., R. L. Reddick, J. A. Piedrahita & N. Maeda: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468-471 (1992)
38. Plump A. S., J. D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J. G. Verstuyft, E. M. Rubin & J. L. Breslow: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343-353 (1992)
39. Park L., K. G. Raman, K. J. Lee, Y. Lu, L. J. Ferran, Jr., W. S. Chow, D. Stern & A. M. Schmidt: Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4, 1025-1031 (1998) (Pubitemid 28417334)
40. Hayek T., K. Hussein, M. Aviram, R. Coleman, S. Keidar, E. Pavoltzky & M. Kaplan: Macrophage-foam cell formation in streptozotocin-induced diabetic mice: Stimulatory effect of glucose. Atherosclerosis 183, 25-33 (2005) (Pubitemid 41416818)
41. Ishibashi S., J. L. Goldstein, M. S. Brown, J. Herz & D. K. Burns: Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93, 1885-1893 (1994) (Pubitemid 24143065)
42. Reaven P., S. Merat, F. Casanada, M. Sutphin & W. Palinski: Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 17, 2250-2256 (1997) (Pubitemid 28057129)
43. Keren P., J. George, A. Shaish, H. Levkovitz, Z. Janakovic, A. Afek, I. Goldberg, J. Kopolovic, G. Keren & D. Harats: Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 49, 1064-1069 (2000) (Pubitemid 30349431)
44. Vikramadithyan R. K., Y. Hu, H. L. Noh, C. P. Liang, K. Hallam, A. R. Tall, R. Ramasamy & I. J. Goldberg: Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Invest 115, 2434-2443 (2005) (Pubitemid 41266205)
45. Kako Y., M. Masse, L. S. Huang, A. R. Tall & I. J. Goldberg: Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice. J Lipid Res 43, 872-877 (2002) (Pubitemid 34602608)
46. Oldstone M. B., M. Nerenberg, P. Southern, J. Price & H. Lewicki: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65, 319-331 (1991) (Pubitemid 121006061)
47. Renard C. B., F. Kramer, F. Johansson, N. Lamharzi, L. R. Tannock, M. G. von Herrath, A. Chait & K. E. Bornfeldt: Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 114, 659-668 (2004) (Pubitemid 39578756)
48. Lamharzi N., C. B. Renard, F. Kramer, S. Pennathur, J. W. Heinecke, A. Chait & K. E. Bornfeldt: Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. Diabetes 53, 3217-3225 (2004) (Pubitemid 39564498)
49. Leiter E. H., M. Prochazka & D. L. Coleman: The nonobese diabetic (NOD) mouse. Am J Pathol 128, 380-383 (1987)
50. Kikutani H. & S. Makino: The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51, 285-322 (1992)
51. Keren P., J. George, G. Keren & D. Harats: Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis. Atherosclerosis 157, 285-292 (2001) (Pubitemid 32710006)
52. Saltiel A. R. & C. R. Kahn: Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806 (2001) (Pubitemid 34000783)
53. Plum L., F. T. Wunderlich, S. Baudler, W. Krone & J. C. Bruning: Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives. Physiology (Bethesda) 20, 152-161 (2005) (Pubitemid 40807053)
54. Surwit R. S., C. M. Kuhn, C. Cochrane, J. A. McCubbin & M. N. Feinglos: Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37, 1163-1167 (1988) (Pubitemid 19035045)
55. Surwit R. S., M. F. Seldin, C. M. Kuhn, C. Cochrane & M. N. Feinglos: Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes 40, 82-87 (1991)
56. Schreyer S. A., C. Vick, T. C. Lystig, P. Mystkowski & R. C. LeBoeuf: LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 282, E207-214 (2002)
57. Surwit R. S., M. N. Feinglos, J. Rodin, A. Sutherland, A. E. Petro, E. C. Opara, C. M. Kuhn & M. Rebuffe-Scrive: Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44, 645-651 (1995)
58. Schreyer S. A., D. L. Wilson & R. C. LeBoeuf: C57BL/6 mice fed high fat diets as models for diabetesaccelerated atherosclerosis. Atherosclerosis 136, 17-24 (1998) (Pubitemid 28341437)
59. Merat S., F. Casanada, M. Sutphin, W. Palinski & P. D. Reaven: Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol 19, 1223-1230 (1999) (Pubitemid 29227641)
60. Schreyer S. A., T. C. Lystig, C. M. Vick & R. C. LeBoeuf: Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity. Atherosclerosis 171, 49-55 (2003) (Pubitemid 37464628)
61. Ragolia L., T. Palaia, C. E. Hall, J. K. Maesaka, N. Eguchi & Y. Urade: Accelerated glucose intolerance, nephropathy and atherosclerosis in prostaglandin D2 synthase knockout mice. J Biol Chem (2005)
62. Le Marchand-Brustel Y.: Molecular mechanisms of insulin action in normal and insulin-resistant states. Exp Clin Endocrinol Diabetes 107, 126-132 (1999) (Pubitemid 29179279)
63. Lyngdorf L. G., S. Gregersen, A. Daugherty & E. Falk: Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes. Cardiovasc Res 59, 854-862 (2003) (Pubitemid 38366241)
64. Hummel K. P., M. M. Dickie & D. L. Coleman: Diabetes, a new mutation in the mouse. Science 153, 1127-1128 (1966)
65. Zhang Y., R. Proenca, M. Maffei, M. Barone, L. Leopold & J. M. Friedman: Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432 (1994) (Pubitemid 24365442)
66. Chua S. C., Jr., W. K. Chung, X. S. Wu-Peng, Y. Zhang, S. M. Liu, L. Tartaglia & R. L. Leibel: Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271, 994-996 (1996) (Pubitemid 26066874)
67. Chen H., O. Charlat, L. A. Tartaglia, E. A. Woolf, X. Weng, S. J. Ellis, N. D. Lakey, J. Culpepper, K. J. Moore, R. E. Breitbart, G. M. Duyk, R. I. Tepper & J. P. Morgenstern: Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84, 491-495 (1996) (Pubitemid 26060722)
68. Coleman D. L.: Obesity genes: beneficial effects in heterozygous mice. Science 203, 663-665 (1979) (Pubitemid 9149465)
69. Sun Y., M. Asnicar, P. K. Saha, L. Chan & R. G. Smith: Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3, 379-386 (2006)
70. Hasty A. H., H. Shimano, J. Osuga, I. Namatame, A. Takahashi, N. Yahagi, S. Perrey, Y. Iizuka, Y. Tamura, M. Amemiya-Kudo, T. Yoshikawa, H. Okazaki, K. Ohashi, K. Harada, T. Matsuzaka, H. Sone, T. Gotoda, R. Nagai, S. Ishibashi & N. Yamada: Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276, 37402-37408 (2001)
71. Liang C. P., S. Han, H. Okamoto, R. Carnemolla, I. Tabas, D. Accili & A. R. Tall: Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest 113, 764-773 (2004) (Pubitemid 38544170)
72. Kjerrulf M., Z. Berke, A. Aspegren, M. Umaerus, T. Nilsson, L. Svensson & E. Hurt-Camejo: Reduced cholesterol accumulation by leptin deficient (ob/ob) mouse macrophages. Inflamm Res 55, 300-309 (2006) (Pubitemid 44359134)
73. Gruen M. L., V. Saraswathi, A. M. Nuotio-Antar, M. R. Plummer, K. R. Coenen & A. H. Hasty: Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice. Atherosclerosis 186, 54-64 (2006)
74. Wu K. K., T. J. Wu, J. Chin, L. J. Mitnaul, M. Hernandez, T. Q. Cai, N. Ren, M. G. Waters, S. D. Wright & K. Cheng: Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor. Atherosclerosis 181, 251-259 (2005) (Pubitemid 41019605)
75. Wendt T., E. Harja, L. Bucciarelli, W. Qu, Y. Lu, L. L. Rong, D. G. Jenkins, G. Stein, A. M. Schmidt & S. F. Yan: RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 185, 70-77 (2006) (Pubitemid 43117552)
76. Kobayashi K., T. M. Forte, S. Taniguchi, B. Y. Ishida, K. Oka & L. Chan: The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 49, 22-31 (2000) (Pubitemid 30054029)
77. Gruen M. L., M. R. Plummer, W. Zhang, K. A. Posey, M. F. Linton, S. Fazio & A. H. Hasty: Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. J Lipid Res 46, 2007-2014 (2005) (Pubitemid 41248498)
78. Li S. L., M. A. Reddy, Q. Cai, L. Meng, H. Yuan, L. Lanting & R. Natarajan: Enhanced Proatherogenic Responses in Macrophages and Vascular Smooth Muscle Cells Derived From Diabetic db/db Mice. Diabetes 55, 2611-2619 (2006) (Pubitemid 44871163)
79. Nandi A., Y. Kitamura, C. R. Kahn & D. Accili: Mouse models of insulin resistance. Physiol Rev 84, 623-647 (2004) (Pubitemid 38365494)
80. Louvi A., D. Accili & A. Efstratiadis: Growthpromoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189, 33-48 (1997) (Pubitemid 27402461)
81. Burks D. J. & M. F. White: IRS proteins and beta-cell function. Diabetes 50 Suppl 1, S140-145 (2001)
82. Kadowaki T.: Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 106, 459-465 (2000) (Pubitemid 30666378)
83. Araki E., M. A. Lipes, M. E. Patti, J. C. Bruning, B. Haag, 3rd, R. S. Johnson & C. R. Kahn: Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372, 186-190 (1994) (Pubitemid 24347839)
84. Tamemoto H., T. Kadowaki, K. Tobe, T. Yagi, H. Sakura, T. Hayakawa, Y. Terauchi, K. Ueki, Y. Kaburagi, S. Satoh & et al.: Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182-186 (1994) (Pubitemid 24347838)
85. Yamauchi T., K. Tobe, H. Tamemoto, K. Ueki, Y. Kaburagi, R. Yamamoto-Honda, Y. Takahashi, F. Yoshizawa, S. Aizawa, Y. Akanuma, N. Sonenberg, Y. Yazaki & T. Kadowaki: Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol Cell Biol 16, 3074-3084 (1996)
86. Withers D. J., D. J. Burks, H. H. Towery, S. L. Altamuro, C. L. Flint & M. F. White: Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 23, 32-40 (1999) (Pubitemid 29418784)
87. Kubota N., K. Tobe, Y. Terauchi, K. Eto, T. Yamauchi, R. Suzuki, Y. Tsubamoto, K. Komeda, R. Nakano, H. Miki, S. Satoh, H. Sekihara, S. Sciacchitano, M. Lesniak, S. Aizawa, R. Nagai, S. Kimura, Y. Akanuma, S. I. Taylor & T. Kadowaki: Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49, 1880-1889 (2000)
88. Burks D. J., J. F. de Mora, M. Schubert, D. J. Withers, M. G. Myers, H. H. Towery, S. L. Altamuro, C. L. Flint & M. F. White: IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407, 377-382 (2000)
89. Lin X., A. Taguchi, S. Park, J. A. Kushner, F. Li, Y. Li & M. F. White: Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 114, 908-916 (2004) (Pubitemid 39578718)
90. Brady M. J.: IRS2 takes center stage in the development of type 2 diabetes. J Clin Invest 114, 886-888 (2004) (Pubitemid 39578713)
91. Hennige A. M., D. J. Burks, U. Ozcan, R. N. Kulkarni, J. Ye, S. Park, M. Schubert, T. L. Fisher, M. A. Dow, R. Leshan, M. Zakaria, M. Mossa-Basha & M. F. White: Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 112, 1521-1532 (2003) (Pubitemid 38056278)
92. Fantin V. R., Q. Wang, G. E. Lienhard & S. R. Keller: Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis. Am J Physiol Endocrinol Metab 278, E127-133 (2000) (Pubitemid 30101929)
93. Liu S. C., Q. Wang, G. E. Lienhard & S. R. Keller: Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J Biol Chem 274, 18093-18099 (1999)
94. Lavan B. E., V. R. Fantin, E. T. Chang, W. S. Lane, S. R. Keller & G. E. Lienhard: A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272, 21403-21407 (1997) (Pubitemid 27374010)
95. Lavan B. E., W. S. Lane & G. E. Lienhard: The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272, 11439-11443 (1997) (Pubitemid 27184151)
96. Han S., C. P. Liang, T. Devries-Seimon, M. Ranalletta, C. L. Welch, K. Collins-Fletcher, D. Accili, I. Tabas & A. R. Tall: Macrophage insulin receptor deficiency increases ER stressinduced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab 3, 257-266 (2006)
97. Griffin E., A. Re, N. Hamel, C. Fu, H. Bush, T. McCaffrey & A. S. Asch: A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation. Nat Med 7, 840-846 (2001) (Pubitemid 32691640)
98. Sampson M. J., I. R. Davies, S. Braschi, K. Ivory & D. A. Hughes: Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes. Atherosclerosis 167, 129-134 (2003) (Pubitemid 36255644)
99. Baumgartl J., S. Baudler, M. Scherner, V. Babaev, L. Makowski, J. Suttles, M. McDuffie, S. Fazio, C. R. Kahn, G. S. Hotamisligil, W. Krone, M. Linton & J. C. Bruning: Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis. Cell Metab 3, 247-256 (2006)
100. Gonzalez-Navarro H., M. Vila-Caballer, M. F. Pastor, A. Vinue, M. F. White, D. Burks & V. Andres: Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice. Front Biosci 12, 2291-2298 (2007)
101. Clough M. H., D. J. Schneider, B. E. Sobel, M. F. White, M. P. Wadsworth & D. J. Taatjes: Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E. J Histochem Cytochem 53, 603-610 (2005) (Pubitemid 40593973)
102. Van Belle E., C. Bauters, E. Hubert, J. C. Bodart, K. Abolmaali, T. Meurice, E. P. McFadden, J. M. Lablanche & M. E. Bertrand: Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96, 1454-1460 (1997) (Pubitemid 27375336)
103. Mercado N., E. Boersma, W. Wijns, B. J. Gersh, C. A. Morillo, V. de Valk, G. A. van Es, D. E. Grobbee & P. W. Serruys: Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 38, 645-652 (2001) (Pubitemid 32835730)
104. Elezi S., A. Kastrati, J. Pache, A. Wehinger, M. Hadamitzky, J. Dirschinger, F. J. Neumann & A. Schomig: Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32, 1866-1873 (1998) (Pubitemid 29010448)
105. Schofer J., M. Schluter, T. Rau, F. Hammer, N. Haag & D. G. Mathey: Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study. J Am Coll Cardiol 35, 1554-1559 (2000) (Pubitemid 30307500)
106. Van Belle E., M. Perie, D. Braune, A. Chmait, T. Meurice, K. Abolmaali, E. P. McFadden, C. Bauters, J. M. Lablanche & M. E. Bertrand: Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 40, 410-417 (2002) (Pubitemid 34833153)
107. Kanzaki T., M. Shinomiya, S. Ueda, N. Morisaki, Y. Saito & S. Yoshida: Enhanced arterial intimal thickening after balloon catheter injury in diabetic animals accompanied by PDGF beta-receptor overexpression of aortic media. Eur J Clin Invest 24, 377-381 (1994) (Pubitemid 24201265)
108. Winocour P. D. & L. Hryhorenko: Spontaneous diabetes in BB Wistar rats causes small increases in the early proliferative response of smooth muscle cells in reinjured aortae. Exp Mol Pathol 63, 161-174 (1995) (Pubitemid 27149445)
109. Stephenson K., J. Tunstead, A. Tsai, R. Gordon, S. Henderson & H. M. Dansky: Neointimal formation after endovascular arterial injury is markedly attenuated in db/db mice. Arterioscler Thromb Vasc Biol 23, 2027-2033 (2003) (Pubitemid 37433196)
110. Park S. H., S. P. Marso, Z. Zhou, F. Foroudi, E. J. Topol & A. M. Lincoff: Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulindependent diabetes mellitus. Circulation 104, 815-819 (2001) (Pubitemid 32762681)
111. Indolfi C., D. Torella, L. Cavuto, A. M. Davalli, C. Coppola, G. Esposito, M. V. Carriero, A. Rapacciuolo, E. Di Lorenzo, E. Stabile, C. Perrino, A. Chieffo, F. Pardo & M. Chiariello: Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 103, 2980-2986 (2001) (Pubitemid 32578138)
112. Haudenschild C. C., W. Van Sickle & A. V. Chobanian: Response of the aorta of the obese Zucker rat to injury. Arteriosclerosis 1, 186-191 (1981) (Pubitemid 11024321)
113. Zhou Z., K. Wang, M. S. Penn, S. P. Marso, M. A. Lauer, F. Forudi, X. Zhou, W. Qu, Y. Lu, D. M. Stern, A. M. Schmidt, A. M. Lincoff & E. J. Topol: Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 107, 2238-2243 (2003) (Pubitemid 36547219)
114. Moroi M., L. Zhang, T. Yasuda, R. Virmani, H. K. Gold, M. C. Fishman & P. L. Huang: Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 101, 1225-1232 (1998) (Pubitemid 28145238)
115. Kubota T., N. Kubota, M. Moroi, Y. Terauchi, T. Kobayashi, K. Kamata, R. Suzuki, K. Tobe, A. Namiki, S. Aizawa, R. Nagai, T. Kadowaki & T. Yamaguchi: Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury. Circulation 107, 3073-3080 (2003) (Pubitemid 36758982)
116. Foster E., S. Zhang & A. M. Kahn: Insulin stimulates arterial neointima formation in normal rats after balloon injury. Diabetes Obes Metab 8, 348-351 (2006)
117. Yang M., E. Foster & A. M. Kahn: Insulin-stimulated NAD (P) H oxidase activity increases migration of cultured vascular smooth muscle cells. Am J Hypertens 18, 1329-1334 (2005) (Pubitemid 41400203)
118. Naka Y., L. G. Bucciarelli, T. Wendt, L. K. Lee, L. L. Rong, R. Ramasamy, S. F. Yan & A. M. Schmidt: RAGE axis: Animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol 24, 1342-1349 (2004) (Pubitemid 39050425)
119. Bucciarelli L. G., T. Wendt, W. Qu, Y. Lu, E. Lalla, L. L. Rong, M. T. Goova, B. Moser, T. Kislinger, D. C. Lee, Y. Kashyap, D. M. Stern & A. M. Schmidt: RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 106, 2827-2835 (2002) (Pubitemid 35396983)
120. Forbes J. M., L. T. Yee, V. Thallas, M. Lassila, R. Candido, K. A. Jandeleit-Dahm, M. C. Thomas, W. C. Burns, E. K. Deemer, S. M. Thorpe, M. E. Cooper & T. J. Allen: Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 53, 1813-1823 (2004) (Pubitemid 38857040)
121. Lin R. Y., R. P. Choudhury, W. Cai, M. Lu, J. T. Fallon, E. A. Fisher & H. Vlassara: Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 168, 213-220 (2003) (Pubitemid 36703319)
122. Shoji T., H. Koyama, T. Morioka, S. Tanaka, A. Kizu, K. Motoyama, K. Mori, S. Fukumoto, A. Shioi, N. Shimogaito, M. Takeuchi, Y. Yamamoto, H. Yonekura, H. Yamamoto & Y. Nishizawa: Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes 55, 2245-2255 (2006) (Pubitemid 44743621)
123. Candido R., K. A. Jandeleit-Dahm, Z. Cao, S. P. Nesteroff, W. C. Burns, S. M. Twigg, R. J. Dilley, M. E. Cooper & T. J. Allen: Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 106, 246-253 (2002) (Pubitemid 34761307)
124. Candido R., T. J. Allen, M. Lassila, Z. Cao, V. Thallas, M. E. Cooper & K. A. Jandeleit-Dahm: Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 109, 1536-1542 (2004) (Pubitemid 38420183)
125. Jandeleit-Dahm K., M. Lassila, B. J. Davis, R. Candido, C. I. Johnston, T. J. Allen, L. M. Burrell & M. E. Cooper: Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice. J Hypertens 23, 2071-2082 (2005) (Pubitemid 41830404)
126. Shawver L. K., D. Slamon & A. Ullrich: Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1, 117-123 (2002)
127. Myllarniemi M., J. Frosen, L. G. Calderon Ramirez, E. Buchdunger, K. Lemstrom & P. Hayry: Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo. Cardiovasc Drugs Ther 13, 159-168 (1999) (Pubitemid 29224842)
128. Boucher P., M. Gotthardt, W. P. Li, R. G. Anderson & J. Herz: LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300, 329-332 (2003) (Pubitemid 36433724)
129. Sihvola R. K., J. M. Tikkanen, R. Krebs, E. M. Aaltola, E. Buchdunger, O. Laitinen, P. K. Koskinen & K. B. Lemstrom: Platelet-derived growth factor receptor inhibition reduces allograft arteriosclerosis of heart and aorta in cholesterol-fed rabbits. Transplantation 75, 334-339 (2003) (Pubitemid 36222958)
130. Lassila M., T. J. Allen, Z. Cao, V. Thallas, K. A. Jandeleit-Dahm, R. Candido & M. E. Cooper: Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler Thromb Vasc Biol 24, 935-942 (2004) (Pubitemid 38620875)
131. Mendelsohn M. E. & R. H. Karas: The protective effects of estrogen on the cardiovascular system. N Engl J Med 340, 1801-1811 (1999) (Pubitemid 29266405)
132. Tse J., B. Martin-McNaulty, M. Halks-Miller, K. Kauser, V. DelVecchio, R. Vergona, M. E. Sullivan & G. M. Rubanyi: Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol. Atherosclerosis 144, 303-313 (1999) (Pubitemid 29305464)
133. Hermanowski-Vosatka A., J. M. Balkovec, K. Cheng, H. Y. Chen, M. Hernandez, G. C. Koo, C. B. Le Grand, Z. Li, J. M. Metzger, S. S. Mundt, H. Noonan, C. N. Nunes, S. H. Olson, B. Pikounis, N. Ren, N. Robertson, J. M. Schaeffer, K. Shah, M. S. Springer, A. M. Strack, M. Strowski, K. Wu, T. Wu, J. Xiao, B. B. Zhang, S. D. Wright & R. Thieringer: 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med 202, 517-527 (2005) (Pubitemid 41186950)
134. Worth N. F., C. L. Berry, A. C. Thomas & J. H. Campbell: S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits. Atherosclerosis 183, 65-73 (2005) (Pubitemid 41416823)
135. Cayatte A. J., Y. Du, J. Oliver-Krasinski, G. Lavielle, T. J. Verbeuren & R. A. Cohen: The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis. Arterioscler Thromb Vasc Biol 20, 1724-1728 (2000) (Pubitemid 30470586)
136. Zuccollo A., C. Shi, R. Mastroianni, K. A. Maitland-Toolan, R. M. Weisbrod, M. Zang, S. Xu, B. Jiang, J. M. Oliver-Krasinski, A. J. Cayatte, S. Corda, G. Lavielle, T. J. Verbeuren & R. A. Cohen: The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus. Circulation 112, 3001-3008 (2005) (Pubitemid 41612304)
137. Lefebvre P., G. Chinetti, J. C. Fruchart & B. Staels: Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116, 571-580 (2006) (Pubitemid 43326861)
138. Staels B., J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf & J. C. Fruchart: Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088-2093 (1998) (Pubitemid 28512236)
139. Calkin A. C., M. E. Cooper, K. A. Jandeleit-Dahm & T. J. Allen: Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation. Diabetologia 49, 766-774 (2006) (Pubitemid 43357552)
140. Calkin A. C., J. M. Forbes, C. M. Smith, M. Lassila, M. E. Cooper, K. A. Jandeleit-Dahm & T. J. Allen: Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects. Arterioscler Thromb Vasc Biol 25, 1903-1909 (2005) (Pubitemid 41243461)
141. Calkin A. C., S. Giunti, K. A. Jandeleit-Dahm, T. J. Allen, M. E. Cooper & M. C. Thomas: PPAR-{alpha} and - {gamma} agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse. Nephrol Dial Transplant 21, 2399-2405 (2006) (Pubitemid 44644510)
142. *3Leiden mice. Arterioscler Thromb Vasc Biol 26, 2560-2566 (2006) (Pubitemid 44607481)
143. Kaliora A. C., G. V. Dedoussis & H. Schmidt: Dietary antioxidants in preventing atherogenesis. Atherosclerosis 187, 1-17 (2006) (Pubitemid 43817017)
144. Zang M., S. Xu, K. A. Maitland-Toolan, A. Zuccollo, X. Hou, B. Jiang, M. Wierzbicki, T. J. Verbeuren & R. A. Cohen: Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor-Deficient Mice. Diabetes 55, 2180-2191 (2006) (Pubitemid 44743614)
145. Yi X. & N. Maeda: {alpha}-Lipoic Acid Prevents the Increase in Atherosclerosis Induced by Diabetes in Apolipoprotein E-Deficient Mice Fed High-Fat/Low-Cholesterol Diet. Diabetes 55, 2238-2244 (2006) (Pubitemid 44743620)
146. Mackness B., R. Quarck, W. Verreth, M. Mackness & P. Holvoet: Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler Thromb Vasc Biol 26, 1545-1550 (2006) (Pubitemid 44288981)